| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 2',4'-二羟基-2,3',6'- 三甲氧基查尔酮; 2',4'-Dihydroxy-2,3',6'-trimethoxychalcone | CFN99015 | 100079-39-8 | C18H18O6 = 330.3 | 5mg | QQ客服：2056216494 |
| Sarcandrone A; Sarcandrone A | CFN99299 | 1190225-47-8 | C33H30O8 = 554.6 | 5mg | QQ客服：1457312923 |
| Sarcandrone B; Sarcandrone B | CFN99300 | 1190225-48-9 | C33H30O8 = 554.6 | 5mg | QQ客服：3257982914 |
| 乙基赤芝酮; Ethyllucidone | CFN99308 | 1195233-59-0 | C17H16O4 = 284.3 | 5mg | QQ客服：1413575084 |
| 2',4'-二羟基-3',6'-二甲氧基查尔酮; 2',4'-Dihydroxy-3',6'-dimethoxychalcone | CFN99391 | 129724-43-2 | C17H16O5 = 300.3 | 5mg | QQ客服：3257982914 |
| 异甘草苷; Isoliquiritin | CFN99155 | 5041-81-6 | C21H22O9 = 418.39 | 20mg | QQ客服：1413575084 |
| 刺甘草查尔酮; Echinatin | CFN99520 | 34221-41-5 | C16H14O4 = 270.28 | 20mg | QQ客服：2159513211 |
| 甘草查尔酮A; Licochalcone A | CFN99575 | 58749-22-7 | C21H22O4 = 338.40 | 20mg | QQ客服：3257982914 |
| 甘草查尔酮B; Licochalcone B | CFN99576 | 58749-23-8 | C16H14O5 = 286.28 | 20mg | QQ客服：1413575084 |
| 甘草查尔酮C; Licochalcone C | CFN99577 | 144506-14-9 | C21H22O4 = 338.40 | 5mg | QQ客服：2159513211 |
| Calyxin B; Calyxin B | CFN99693 | 164991-53-1 | C35H34O8 = 582.7 | 5mg | QQ客服：2159513211 |
| 乌药环戊烯二酮; Linderone | CFN99837 | 1782-79-2 | C16H14O5 = 286.3 | 5mg | QQ客服：2056216494 |
| 球松素查尔酮; Pinostrobin chalcone | CFN99878 | 18956-15-5 | C16H14O4 = 270.3 | 20mg | QQ客服：1413575084 |
| 小豆蔻明; Cardamonin | CFN99890 | 19309-14-9 | C16H14O4 = 270.3 | 20mg | QQ客服：1413575084 |
| 羟基红花黄色素A; Hydroxysafflor yellow A | CFN99950 | 78281-02-4 | C27H32O16 = 612.53 | 20mg | QQ客服：215959384 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)